Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target. | Mol Biomed | 2026 | 41795043 | PubTator, text mining | PubMed |
| ACSL4 mediates ferroptosis to promote immunoglobulin A nephropathy progression: scRNA-seq analysis. | Sci Rep | 2026 | 41794881 | PubTator, text mining | PubMed |
| The dual role of the crosstalk between autophagy and ferroptosis in lung cancer treatment: Advances in mechanisms and therapeutic strategies (Review). | Int J Mol Med | 2026 | 41789644 | PubTator, text mining | PubMed |
| Circular RNAs in sepsis-induced acute lung injury: emerging mechanisms and therapeutic potential. | Front Immunol | 2026 | 41789098 | PubTator, text mining | PubMed |
| The role of Piezo1 in immune cells and pregnancy. | Front Immunol | 2026 | 41789063 | PubTator, text mining | PubMed |
| Succinylation: novel molecular mechanisms and prospects for targeted therapy in liver diseases. | Front Mol Biosci | 2026 | 41788628 | PubTator, text mining | PubMed |
| Lactylation: a metabolic-epigenetic bridge in diabetic kidney disease and a therapeutic target for TCM. | Chin Med | 2026 | 41787542 | PubTator, text mining | PubMed |
| Targeting SLC6A8 suppresses tumor growth and enhances ferroptosis in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2026 | 41787198 | PubTator, text mining | PubMed |
| Application of a novel myristoylproteomics approach identifies GLIPR2 as a key pro-ferroptotic substrate in non-small cell lung cancer. | Mater Today Bio | 2026 | 41782991 | PubTator, text mining | PubMed |
| Potential of SP1 as a prognostic marker and therapeutic target in acute myocardial infarction: a bioinformatics, Mendelian randomization and experimental validation study. | Front Immunol | 2026 | 41782887 | PubTator, text mining | PubMed |
| Breaking through the radiation dilemma: development and clinical translation of anti-radiation drugs. | Pharm Sci Adv | 2026 | 41782615 | PubTator, text mining | PubMed |
| ANO6 Confers Paclitaxel Resistance by Targeting Ferroptosis in Cervical Cancer. | Biofactors | 2026 | 41782241 | PubTator, text mining | PubMed |
| Lipid metabolism drives dietary effects on T cell ferroptosis and immunity. | Nature | 2026 | 41781622 | PubTator, text mining | PubMed |
| Mechanism of CircBbs9 in Lung Epithelial Cell Ferroptosis in Lipopolysaccharide-Induced Acute Lung Injury. | FASEB J | 2026 | 41779432 | PubTator, text mining | PubMed |
| Lactotransferrin upregulation affects the pathological changes of non-small cell lung cancer by regulating ferroptosis. | PeerJ | 2026 | 41777684 | PubTator, text mining | PubMed |
| Dysregulation of ferroptosis-related genes and the ACSL4-mediated ferroptosis-PD-L1 axis in prostate cancer pathogenesis. | Cancer Cell Int | 2026 | 41776636 | PubTator, text mining | PubMed |
| Polystyrene Nanoplastics induced placental toxicology by activating Keap1-mediated ferroptosis via METTL3-dependent m6A methylation. | Cell Biol Toxicol | 2026 | 41776140 | PubTator, text mining | PubMed |
| KCNJ2-AS1 Drives Inflammation and Ferroptosis via the miR-212-3p/EGR1 Axis in Sepsis-Associated Acute Lung Injury. | J Biochem Mol Toxicol | 2026 | 41773921 | PubTator, text mining | PubMed |
| Exosomes as Pivotal Mediators of Tumor-Immune Communication: Implications for Immunotherapy and Liquid Biopsy. | Int J Nanomedicine | 2026 | 41773242 | PubTator, text mining | PubMed |
| Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. | Mol Biomed | 2026 | 41772328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=17